Audit 17046

FY End
2022-06-30
Total Expended
$18.08M
Findings
2
Programs
8
Year: 2022 Accepted: 2023-03-29
Auditor: Gbq Partners LLC

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
12506 2022-001 - - L
588948 2022-001 - - L

Programs

Contacts

Name Title Type
NCBNNNMBAEL3 Maureen Thomas Auditee
3802344777 Mike Purcell Auditor
No contacts on file

Notes to SEFA

Title: Loan/loan guarantee outstanding balances Accounting Policies: The accompanying schedule of expenditures of federal awards includes the federal award activity of ECDI under programs of the federal government for the year ended June 30, 2022 in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the schedule presents only a selected portion of the operations of ECDI, it is not intended to and does not present the financial position, changes in net assets, or cash flows of ECDI. De Minimis Rate Used: Y Rate Explanation: The auditee used the de minimis cost rate. RURAL MICROENTREPRENEUR ASSISTANCE PROGRAM (10.870) - Balances outstanding at the end of the audit period were 610886. MICROLOAN PROGRAM (59.046) - Balances outstanding at the end of the audit period were 8603413.

Finding Details

Finding Type: Immaterial noncompliance with major program requirements Title and CFDA Number of Federal Program: 21.020 - CDFI Cluster - U.S. Department of Treasury Finding Resolution Status: Resolved Information on Universe and Population Size: All CDFI reports pursuant to the mutually agreed upon Reporting Schedule, which for fiscal year 2022 totaled 17 reports for all CDFI-FA awards. Sample Size Information: A sample of 3 reports for fiscal year 2022 were selected for testing compliance with reporting pursuant to the mutually agreed upon Reporting Schedule. Identification of Repeat Finding and Finding Reference Number: N/A Criteria: The Organization is required to submit the financial statement audit report by December 31, 2022. Statement of Condition: The Organization failed to submit the financial statement audit report by December 31, 2022. The financial statement audit report was filed January 1, 2023. Cause: The due date of December 31, 2022 was a Saturday. The Organization incorrectly concluded that the due date would therefore fall on the next business day, which would be Monday, January 2, 2023. Effect or Potential Effect: The Organization is noncompliant for the performance period ended June 30, 2022 with no sanctions imposed. The Organization submitted the requested report within the 30 day cure period. Auditor Noncompliance Code: L ? Reporting Reporting Views of Responsible Officials: Management agrees with the noncompliance with no sanctions imposed conclusion as communicated by the CDFI Fund. Context: The Organization incorrectly concluded that the due date would therefore fall on the next business day, which would be Monday, January 2, 2023. Upon learning of noncompliance the Organization submitted the requested report on Sunday, January 1, 2023. Recommendation: All requested reports should be submitted in accordance with the mutually agreed upon Reporting Schedule. Auditor?s Summary of the Auditee?s Comments on the Findings and Recommendations: Management should submit all requested reports in accordance with the mutually agreed upon Reporting Schedule, including prior to the due date if the due date falls on a non-business day. Response Indicator: Agree Completion Date: January 1, 2023 Response: Management acknowledges noncompliance in the current fiscal year and has submitted the requested report within the 30 day cure period.
Finding Type: Immaterial noncompliance with major program requirements Title and CFDA Number of Federal Program: 21.020 - CDFI Cluster - U.S. Department of Treasury Finding Resolution Status: Resolved Information on Universe and Population Size: All CDFI reports pursuant to the mutually agreed upon Reporting Schedule, which for fiscal year 2022 totaled 17 reports for all CDFI-FA awards. Sample Size Information: A sample of 3 reports for fiscal year 2022 were selected for testing compliance with reporting pursuant to the mutually agreed upon Reporting Schedule. Identification of Repeat Finding and Finding Reference Number: N/A Criteria: The Organization is required to submit the financial statement audit report by December 31, 2022. Statement of Condition: The Organization failed to submit the financial statement audit report by December 31, 2022. The financial statement audit report was filed January 1, 2023. Cause: The due date of December 31, 2022 was a Saturday. The Organization incorrectly concluded that the due date would therefore fall on the next business day, which would be Monday, January 2, 2023. Effect or Potential Effect: The Organization is noncompliant for the performance period ended June 30, 2022 with no sanctions imposed. The Organization submitted the requested report within the 30 day cure period. Auditor Noncompliance Code: L ? Reporting Reporting Views of Responsible Officials: Management agrees with the noncompliance with no sanctions imposed conclusion as communicated by the CDFI Fund. Context: The Organization incorrectly concluded that the due date would therefore fall on the next business day, which would be Monday, January 2, 2023. Upon learning of noncompliance the Organization submitted the requested report on Sunday, January 1, 2023. Recommendation: All requested reports should be submitted in accordance with the mutually agreed upon Reporting Schedule. Auditor?s Summary of the Auditee?s Comments on the Findings and Recommendations: Management should submit all requested reports in accordance with the mutually agreed upon Reporting Schedule, including prior to the due date if the due date falls on a non-business day. Response Indicator: Agree Completion Date: January 1, 2023 Response: Management acknowledges noncompliance in the current fiscal year and has submitted the requested report within the 30 day cure period.